U.S, January 20, 2020 (ANALYTICALCANNABIS) Marijuana use is rising among US patients with cardiovascular disease, researchers have warned.
Published in the Journal of the American College of Cardiology today, a new review article has estimated that 2 million US marijuana users were living with cardiovascular...
AUSTRALIAN, January 21, 2020 (HEMPGAZETTE) There’s a lot of activity on the Australian cannabusiness scene, but what is happening at the patient end of things? Statistics from the Therapeutic Goods Administration (TGA) indicate significant growth in approvals, but it wouldn’t even be touching the sides of potential...
The 400-plus chemical compounds in cannabis have the potential to treat more than a dozen medical conditions. Cannabinoids are the most abundant molecules, and scientists have identified over 100 of them.
Medical professionals and other researchers are still in the infancy stage of cannabinoid medicine. However, the current data is...
U.S, January 29, 2020 (ANALYTICALCANNABIS) Several recent studies have suggested that CBD has an antipsychotic effect in people with existing forms of psychosis. But just how the cannabis compound is achieving this effect has remained unclear. Now, researchers from King’s College London say they may know the answer....
US, November 1, 2019 (HEMPGAZETTE) A $1 million U.S. Department of Agriculture grant is supporting Purdue University research into organic hemp production.
Much knowledge has been lost in the USA between the start of prohibition decades ago and the recent hemp renaissance; particularly in relation to growing hemp without the...
CANADA, February 4, 2020 (HEMPINDUSTRY) Editor’s note: This is part of an occasional series on retailing trends in the hemp industry.
Canada’s federal health regulator is reviewing the potential market for cannabis health products that would not require physician oversight, a review that...